Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Urology
|
June 20, 2025
Reply: Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value
Mariluz Rojo Domingo, Tyler M Seibert
Scientific Reports
|
December 29, 2024
Utility of quantitative measurement of T<sub>2</sub> using restriction spectrum imaging for detection of clinically significant prostate cancer
Mariluz Rojo Domingo, Christopher C Conlin, Roshan Karunamuni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 2023
ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging
Asona J Lui, Karoline Kallis, Allison Y Zhong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 26, 2024
Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost
Allison Y Zhong, Asona J Lui, Svetlana Kuznetsova, et al.
Clinical and Translational Radiation Oncology
|
May 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer
Anna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer
Yuze Song, Mariluz Rojo Domingo, Lily Nguyen, et al.
Journal of Applied Clinical Medical Physics
|
March 19, 2026
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI
Deondre D Do, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science
|
February 16, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance Imaging
Yuze Song, Mariluz Rojo Domingo, Christopher C Conlin, et al.
The Journal of Urology
|
June 24, 2025
Reply by Authors
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology
|
May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Urology
|
June 20, 2025
Reply: Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value
Mariluz Rojo Domingo, Tyler M Seibert
Scientific Reports
|
December 29, 2024
Utility of quantitative measurement of T<sub>2</sub> using restriction spectrum imaging for detection of clinically significant prostate cancer
Mariluz Rojo Domingo, Christopher C Conlin, Roshan Karunamuni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 2023
ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging
Asona J Lui, Karoline Kallis, Allison Y Zhong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 26, 2024
Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost
Allison Y Zhong, Asona J Lui, Svetlana Kuznetsova, et al.
Clinical and Translational Radiation Oncology
|
May 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer
Anna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer
Yuze Song, Mariluz Rojo Domingo, Lily Nguyen, et al.
Journal of Applied Clinical Medical Physics
|
March 19, 2026
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI
Deondre D Do, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science
|
February 16, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance Imaging
Yuze Song, Mariluz Rojo Domingo, Christopher C Conlin, et al.
The Journal of Urology
|
June 24, 2025
Reply by Authors
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology
|
May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Page
of 2